Bart is the Managing Partner at Thia Ventures, where he invests globally at the intersection of food, biotech and health. He has a longstanding career in biotechnology investing, having led the oncology-focused fund Droia Ventures. Bart started his career at BCG, and later combined active investing with board mandates in innovation. Recognising the critical importance of novel technology in securing our food supply, he founded Thia with his BCG colleague and former Louis Dreyfus Company CEO, Serge Schoen.